Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC. Gallina FT, Balzano V, Porciello N, Taje R, et al. Lung Cancer 2024;194:107900.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gallina FT, Balzano V, Porciello N, Taje R, et al. Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC. Lung Cancer 2024;194:107900.
PMID: 39079181